Post Traumatic Stress Disorder (PTSD) Clinical Trial
Official title:
Pharmacogenetic Clinical Trial of Nepicastat for PTSD
Assess the effect of nepicastat in the treatment of in Post Traumatic Stress Disorder (PTSD) in conflict or combat zone experienced veterans, in comparison to placebo.
The primary treatment objective is to assess the global efficacy of nepicastat in the
treatment of hyper-arousal in Post Traumatic Stress Disorder (PTSD) in conflict or combat
zone experienced veterans, in comparison to placebo. The secondary treatment objectives are
to assess the ability of nepicastat to induce PTSD remission; treat PTSD and other PTSD
symptom clusters and improve quality of life and overall functioning. A medical safety
objective is to assess the tolerability and side effects of nepicastat in the treatment of
PTSD in veterans who served in conflict zones at least one time between 1990 -2008 [includes
Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF), Afghanistan, Gulf War, etc .
This is a 6-week study with the long-term objective is to define the best approach to
treating PTSD and enhancing the quality of life in patients. Results from this pilot study
will assist clinicians in treating active military service members or veterans with PTSD by
developing new treatment algorithms for future larger studies.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00554177 -
A Clinical Trial for Post Traumatic Stress Disorder
|
Phase 1 | |
Recruiting |
NCT01545505 -
Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse
|
N/A | |
Completed |
NCT02966873 -
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
|
Phase 2 | |
Completed |
NCT04827056 -
Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
|
Phase 1 | |
Completed |
NCT04073862 -
The Norwegian Stepped-Care TF-CBT Study
|
N/A | |
Recruiting |
NCT05254379 -
Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain
|
N/A | |
Terminated |
NCT02077972 -
Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT04086654 -
Psychometric Properties of the International Trauma Interview (ITI) for ICD-11 PTSD and CPTSD
|
N/A | |
Completed |
NCT02723097 -
A Pilot Test of the Relaxation Response Resiliency Program (3RP) in Spanish Speaking World Trade Center Survivors With Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT01629537 -
A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder
|
Phase 2 | |
Recruiting |
NCT04558437 -
COVID-Impact "Psychological IMPACT of Covid-19 on AP-HP Staff"
|
||
Not yet recruiting |
NCT06162741 -
Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans
|
N/A | |
Completed |
NCT02764983 -
Occupational Therapy Driving Intervention for Returning Combat Veterans.
|
N/A | |
Completed |
NCT02765672 -
Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans
|
N/A | |
Not yet recruiting |
NCT06335407 -
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
|
Phase 1 |